Analyst Ratings for Emergent BioSolutions (EBS)
EBS Rating Summary
EBS Price Target Summary
- Highest: $16.00 (Rodman & Renshaw)
- Lowest: $12.00 (Benchmark)
- Average: $14.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.33 (+152.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$14.33 (+152.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/30/2024 | H.C. Wainwright » Updated 3/4/2025 |
Raghuram Selvaraju | New Coverage | Buy (N/A) |
15.00 (N/A) |
8.27 (5.68) |
-31.32% | Details |
| 8/22/2024 | Rodman & Renshaw | N/A | New Coverage | Buy (N/A) |
16.00 (N/A) |
10.49 (5.68) |
-45.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
